{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Algie post-zona : Questions médicales les plus fréquentes",
"headline": "Algie post-zona : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Algie post-zona : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-13",
"dateModified": "2025-04-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Algie post-zona"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Névralgie",
"url": "https://questionsmedicales.fr/mesh/D009437",
"about": {
"@type": "MedicalCondition",
"name": "Névralgie",
"code": {
"@type": "MedicalCode",
"code": "D009437",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.612.664"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Algie post-zona",
"alternateName": "Neuralgia, Postherpetic",
"code": {
"@type": "MedicalCode",
"code": "D051474",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Song Cao",
"url": "https://questionsmedicales.fr/author/Song%20Cao",
"affiliation": {
"@type": "Organization",
"name": "Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Dexin Zhang",
"url": "https://questionsmedicales.fr/author/Dexin%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Jie Yuan",
"url": "https://questionsmedicales.fr/author/Jie%20Yuan",
"affiliation": {
"@type": "Organization",
"name": "Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Ying Li",
"url": "https://questionsmedicales.fr/author/Ying%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Yuanyuan Ding",
"url": "https://questionsmedicales.fr/author/Yuanyuan%20Ding",
"affiliation": {
"@type": "Organization",
"name": "Department of Pain Management, Shengjing Hospital of China Medical University, Shenyang, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Questions raised by a case of adult-onset linear nodular scleroderma.",
"datePublished": "2022-10-15",
"url": "https://questionsmedicales.fr/article/36809134",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5070/D328559245"
}
},
{
"@type": "ScholarlyArticle",
"name": "Management Options for Linear Scleroderma (\"En Coup de Sabre\").",
"datePublished": "2022-07-22",
"url": "https://questionsmedicales.fr/article/35985009",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/DSS.0000000000003539"
}
},
{
"@type": "ScholarlyArticle",
"name": "Scleroderma and Raynaud Phenomenon: The Cold Truth Regarding the Use of Operative Management.",
"datePublished": "2022-05-10",
"url": "https://questionsmedicales.fr/article/35544320",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/PRS.0000000000009187"
}
},
{
"@type": "ScholarlyArticle",
"name": "Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis.",
"datePublished": "2022-07-31",
"url": "https://questionsmedicales.fr/article/35921989",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.autrev.2022.103162"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis.",
"datePublished": "2022-10-11",
"url": "https://questionsmedicales.fr/article/36304460",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.1004949"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Manifestations neurologiques",
"item": "https://questionsmedicales.fr/mesh/D009461"
},
{
"@type": "ListItem",
"position": 5,
"name": "Névralgie",
"item": "https://questionsmedicales.fr/mesh/D009437"
},
{
"@type": "ListItem",
"position": 6,
"name": "Algie post-zona",
"item": "https://questionsmedicales.fr/mesh/D051474"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Algie post-zona - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Algie post-zona",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Algie post-zona",
"description": "Comment diagnostique-t-on l'algie post-zona ?\nQuels examens peuvent être réalisés ?\nQuels symptômes indiquent une algie post-zona ?\nPeut-on confondre l'algie post-zona avec d'autres douleurs ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Algie post-zona",
"description": "Quels sont les symptômes principaux de l'algie post-zona ?\nLa douleur est-elle constante ou intermittente ?\nY a-t-il des symptômes associés ?\nComment la douleur est-elle décrite par les patients ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Algie post-zona",
"description": "Peut-on prévenir l'algie post-zona ?\nQui devrait se faire vacciner contre le zona ?\nY a-t-il des mesures à prendre après une éruption de zona ?\nLa gestion du stress aide-t-elle à prévenir l'algie ?\nLes soins de la peau sont-ils importants après le zona ?",
"url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Algie post-zona",
"description": "Quels traitements sont efficaces contre l'algie post-zona ?\nLes médicaments topiques sont-ils utiles ?\nLa physiothérapie peut-elle aider ?\nY a-t-il des traitements non médicamenteux ?\nLes traitements sont-ils toujours efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Algie post-zona",
"description": "Quelles sont les complications possibles de l'algie post-zona ?\nL'algie post-zona peut-elle affecter la qualité de vie ?\nY a-t-il un risque de dépression avec l'algie post-zona ?\nLes douleurs peuvent-elles s'aggraver avec le temps ?\nDes infections peuvent-elles survenir après le zona ?",
"url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Algie post-zona",
"description": "Quels sont les facteurs de risque de l'algie post-zona ?\nLe stress est-il un facteur de risque ?\nLes personnes atteintes de maladies chroniques sont-elles à risque ?\nLes femmes sont-elles plus à risque que les hommes ?\nL'immunosuppression augmente-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on l'algie post-zona ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical et l'examen physique, sans tests spécifiques."
}
},
{
"@type": "Question",
"name": "Quels examens peuvent être réalisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens d'imagerie comme l'IRM peuvent être utilisés pour exclure d'autres causes de douleur."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une algie post-zona ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une douleur intense, brûlante ou lancinante dans la zone de l'éruption cutanée est typique."
}
},
{
"@type": "Question",
"name": "Peut-on confondre l'algie post-zona avec d'autres douleurs ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec d'autres douleurs neuropathiques ou musculo-squelettiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique d'une infection par le virus varicelle-zona est crucial pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux de l'algie post-zona ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur intense, hypersensibilité et parfois démangeaisons."
}
},
{
"@type": "Question",
"name": "La douleur est-elle constante ou intermittente ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur peut être constante ou survenir par épisodes, souvent aggravée par le toucher."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, l'anxiété et des troubles du sommeil peuvent être présents."
}
},
{
"@type": "Question",
"name": "Comment la douleur est-elle décrite par les patients ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients décrivent souvent la douleur comme brûlante, lancinante ou en coup de poignard."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la durée des symptômes peuvent varier considérablement entre les individus."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'algie post-zona ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination contre le zona peut réduire le risque de développer l'algie post-zona."
}
},
{
"@type": "Question",
"name": "Qui devrait se faire vacciner contre le zona ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les adultes de 50 ans et plus sont recommandés pour recevoir le vaccin contre le zona."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures à prendre après une éruption de zona ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter un médecin rapidement après une éruption pour un traitement précoce."
}
},
{
"@type": "Question",
"name": "La gestion du stress aide-t-elle à prévenir l'algie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress peut aider à réduire le risque de douleurs chroniques après le zona."
}
},
{
"@type": "Question",
"name": "Les soins de la peau sont-ils importants après le zona ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir la peau propre et hydratée peut aider à prévenir les complications cutanées."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre l'algie post-zona ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des analgésiques, des anticonvulsivants et des antidépresseurs."
}
},
{
"@type": "Question",
"name": "Les médicaments topiques sont-ils utiles ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des crèmes anesthésiques peuvent soulager la douleur localement dans certains cas."
}
},
{
"@type": "Question",
"name": "La physiothérapie peut-elle aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La physiothérapie peut aider à gérer la douleur et améliorer la fonction dans certains cas."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non médicamenteux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme la thérapie cognitivo-comportementale peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils toujours efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité des traitements varie, et certains patients peuvent ne pas répondre aux thérapies."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de l'algie post-zona ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des douleurs chroniques, des troubles du sommeil et de l'anxiété."
}
},
{
"@type": "Question",
"name": "L'algie post-zona peut-elle affecter la qualité de vie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur chronique peut significativement impacter la qualité de vie et le bien-être."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de dépression avec l'algie post-zona ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur chronique peut augmenter le risque de dépression chez les patients."
}
},
{
"@type": "Question",
"name": "Les douleurs peuvent-elles s'aggraver avec le temps ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, la douleur peut devenir plus intense et persistante avec le temps."
}
},
{
"@type": "Question",
"name": "Des infections peuvent-elles survenir après le zona ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections cutanées peuvent survenir si la peau est lésée pendant l'éruption."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'algie post-zona ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, un système immunitaire affaibli et des antécédents de zona."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'algie post-zona."
}
},
{
"@type": "Question",
"name": "Les personnes atteintes de maladies chroniques sont-elles à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies chroniques peuvent augmenter le risque de développer l'algie post-zona."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque que les hommes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que les femmes peuvent être légèrement plus à risque que les hommes."
}
},
{
"@type": "Question",
"name": "L'immunosuppression augmente-t-elle le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunosupprimées ont un risque accru de développer l'algie post-zona."
}
}
]
}
]
}
Morphea presenting clinically with nodular or keloidal skin changes is extremely rare. Nodular scleroderma or keloidal morphea presenting in a linear distribution is even more uncommon. We present an ...
En coup de sabre (ECDS) is a form of linear-scleroderma, primarily affecting the face. Despite effectiveness of pharmacological interventions in the management of lesions, sequelae of cutaneous deform...
Review the existing surgical tools for the correction of "en coup de sabre" ECDS lesions and facial deformities....
The authors conducted a literature search for reports on surgical interventions for ECDS deformations, in the electronic databases of PubMed, Scopus, and Cochrane Library Databases....
Twenty-six publications reporting 39 patients were found in the literature. The average age of patients was 25 ± 4.7 years. Thirty-one of the patients were females. Six methods were found in the liter...
Different surgical and minimally invasive options exist in the armamentarium of clinicians correcting ECDS deformities. Tailoring the method of correction to patient's needs and expectation is crucial...
Raynaud phenomenon, with and without scleroderma, is a common vasospastic condition that manifests with extremity pain and skin discoloration. When conservative management fails, complications such as...
A national insurance claims-based database with patient records from the Centers for Medicare and Medicaid Services was used for data collection. Patients with first diagnoses of Raynaud phenomenon, s...
The Raynaud phenomenon, scleroderma, and Raynaud phenomenon with scleroderma cohorts consisted of 161,300, 117,564, and 25,096 patients, respectively. A diagnosis of both Raynaud phenomenon and sclero...
Patients with both Raynaud phenomenon and scleroderma have higher likelihoods of having upper extremity amputations, vascular procedures, and amputations following vascular procedures compared to each...
Risk, II....
To describe systemic sclerosis (SSc) heart involvement in the ICU....
We retrospectively studied patients with previous diagnosis of SSc admitted to the ICU for acute cardiac dysfunction between 2012 and mid-2021....
9 female patients were included, mainly with diffuse SSc (n = 7, 78%). Six (67%) had digital ulcers. All but one patient complained about physical cardiac symptoms (n = 8, 89%), 5 (56%) had electrocar...
We report an uncommon and specific severe acute life-threatening cardiac dysfunction in SSc patients, which can be reversible but remains associated with a poor long-term prognosis, which can be rever...
Recent evidence has indicated that alterations in energy metabolism play a critical role in the pathogenesis of fibrotic diseases. Studies have suggested that 'metabolic reprogramming' involving the g...
Dermal fibroblasts were isolated from five SSc patients and five healthy donors. Cells were cultured in medium with/without TGF-β1 and with/without ALK5, pan-PIM or ATM kinase inhibitors. Extracellula...
Enhanced mitochondrial respiration coupled to ATP production was observed in SSc fibroblasts at the expense of spare respiratory capacity. Although no difference was found in glycolysis when comparing...
Our data provide evidence for a novel mechanism(s) by which SSc fibroblasts exhibit altered metabolic programs and highlight changes in respiration and dysregulated mitochondrial morphology and functi...
Localized scleroderma (LS), also called circumscribed scleroderma or morphea, comprises a heterogeneous group of diseases that can be classified into four subtypes: limited, linear, generalized, and m...
Patients with diffuse cutaneous systemic sclerosis (dcSSc) display a complex clinical phenotype. Transcriptional profiling of whole blood or tissue from patients are affected by changes in cellular co...
SSc patients were recruited from the Prospective Registry for Early Systemic Sclerosis. Clinical data were collected, as well as peripheral blood for isolation of CMs and NCMs. Age-, sex-, and race-ma...
We used an unbiased approach to cluster patients into 3 groups (groups A-C) based on the transcriptional signatures of CMs relative to controls. Each group maintained their characteristic transcriptio...
We are the first to show that transcriptional signatures of CMs and NCMs can be used to unbiasedly stratify SSc patients and correlate with disease activity outcome measures....
Scleroderma renal crisis (SRC) is a rare and severe manifestation of systemic sclerosis (SSc). Although it is well documented that Black patients with SSc have worse morbidity and mortality than non-B...
Using the electronic health record of the US Military Health System, we conducted a comprehensive chart review of each patient with SSc from 2005 to 2016. The final study cohort was comprised of 31 SR...
Of 353 patients, 294 had identifiable race (79 Black, 215 non-Black). Thirteen of 79 Black patients (16.5%) versus 16 of 215 (7.4%) non-Black patients developed SRC (P = 0.02). On adjusted analysis, B...
Black race was independently associated with a higher risk of future SRC. Further studies are needed to elucidate the mechanisms that underlie this important association....
Nailfold videocapillaroscopy is the gold standard for the early differentiation of primary and secondary Raynaud's phenomenon. Advances in high-frequency ultrasound with superb microvascular imaging s...
Pulmonary arterial hypertension (PAH) is a severe, high mortality and progressive disease. Early diagnosis and treatment improves the prognosis. Patients with scleroderma disease presents high risk of...
Prospective study of 52 consecutive patients diagnosed of scleroderma in our health area, during 2 years (2018 and 2019). All of them undergo CPET, in addition to the annual systematic screening. Sens...
Fifty-two CPET were performed, of which 16 suggested PAH. Resting RHC confirmed PAH in 5 patients and exercise RHC in 7 (diagnostic sensitivity of CPET together with rest and exercise catheterization ...
CPET and exercise RHC could detect PAH earlier than established screening in patients with scleroderma disease, allowing early diagnosis....